Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/289040
COMPARTIR / EXPORTAR:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Invitar a revisión por pares abierta
Título

Computational Biology Dynamics of Mps1 Kinase Molecular Interactions with Isoflavones Reveals a Chemical Scaffold with Potential to Develop New Therapeutics for the Treatment of Cancer

AutorPugh, Lauren; Pancholi, Alisha; Purat, Priscila Celeste; Agudo-Álvarez, Sandra; Benito-Arenas, Raúl; Bastida, Agatha CSIC ORCID ; Bolanos-Garcia, Victor M.
Palabras claveMps1
Cancer
poor prognosis tumours
flavonoid-like compounds
bioinformatics
molecular docking
Fecha de publicación2022
EditorMolecular Diversity Preservation International
CitaciónInternational Journal of Molecular Sciences 23 (2022)
ResumenThe protein kinase Mps1 (monopolar spindle 1) is an important regulator of the Spindle Assembly Checkpoint (SAC), the evolutionary conserved checkpoint system of higher organisms that monitors the proper bipolar attachment of all chromosomes to the mitotic spindle during cell division. Defects in the catalytic activity and the transcription regulation of Mps1 are associated with genome instability, aneuploidy, and cancer. Moreover, multiple Mps1 missense and frameshift mutations have been reported in a wide range of types of cancer of different tissue origin. Due to these features, Mps1 arises as one promising drug target for cancer therapy. In this contribution, we developed a computational biology approach to study the dynamics of human Mps1 kinase interaction with isoflavones, a class of natural flavonoids, and compared their predicted mode of binding with that observed in the crystal structure of Mps1 in complex with reversine, a small-sized inhibitor of Mps1 and Aurora B kinases. We concluded that isoflavones define a chemical scaffold that can be used to develop new Mps1 inhibitors for the treatment of cancer associated with Mps1 amplification and aberrant chromosome segregation. In a broader context, the present report illustrates how modern chemoinformatics approaches can accelerate drug development in oncology.
Versión del editorhttp://dx.doi.org/10.3390/ijms232214228
URIhttp://hdl.handle.net/10261/289040
DOI10.3390/ijms232214228
Identificadoresdoi: 10.3390/ijms232214228
issn: 1422-0067
Aparece en las colecciones: (IQOG) Artículos




Ficheros en este ítem:
Fichero Descripción Tamaño Formato
ijms-23-14228.pdf4,9 MBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo

CORE Recommender

SCOPUSTM   
Citations

1
checked on 20-abr-2024

WEB OF SCIENCETM
Citations

1
checked on 23-feb-2024

Page view(s)

25
checked on 24-abr-2024

Download(s)

30
checked on 24-abr-2024

Google ScholarTM

Check

Altmetric

Altmetric


Este item está licenciado bajo una Licencia Creative Commons Creative Commons